Publicaciones en colaboración con investigadores/as de Universidad Autónoma de Madrid (105)

2023

  1. Control of a hippocampal recurrent excitatory circuit by cannabinoid receptor-interacting protein Gap43

    Nature Communications, Vol. 14, Núm. 1

  2. Identification of NRF2 Activation as a Prognostic Biomarker in T-Cell Acute Lymphoblastic Leukaemia

    International Journal of Molecular Sciences, Vol. 24, Núm. 12

  3. Identification of fatty acid amide hydrolase as a metastasis suppressor in breast cancer

    Nature Communications, Vol. 14, Núm. 1

  4. Ludificación y mentoría en Ingeniería Genética: construcción de unjuego docente sobre la infraestructura LAMP

    II Jornada «Aprendizaje Eficaz con TIC en la UCM» (Ediciones Complutense), pp. 41-52

2022

  1. A Dual Role for FADD in Human Precursor T-Cell Neoplasms

    International Journal of Molecular Sciences, Vol. 23, Núm. 23

  2. New Statement about NRF2 in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia

    Biomolecules, Vol. 12, Núm. 9

2021

  1. Cannabinoid receptor CB2 ablation protects against TAU induced neurodegeneration

    Acta Neuropathologica Communications, Vol. 9, Núm. 1

  2. Central activation of alpha7 nicotinic signaling attenuates lps-induced neuroinflammation and sickness behavior in adult but not in aged animals

    Molecules, Vol. 26, Núm. 8

  3. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  4. IGF-1 facilitates extinction of conditioned fear

    eLife, Vol. 10

2020

  1. Boron Dipyrromethene (BODIPY) as Electron-Withdrawing Group in Asymmetric Copper-Catalyzed [3+2] Cycloadditions for the Synthesis of Pyrrolidine-Based Biological Sensors

    Advanced Synthesis and Catalysis, Vol. 362, Núm. 6, pp. 1345-1355

  2. Na+ controls hypoxic signalling by the mitochondrial respiratory chain

    Nature, Vol. 586, Núm. 7828, pp. 287-291

  3. Raloxifene and n-Acetylcysteine Ameliorate TGF-Signalling in Fibroblasts from Patients with Recessive Dominant Epidermolysis Bullosa

    Cells, Vol. 9, Núm. 9

2019

  1. Therapeutic targeting of HER2–CB 2 R heteromers in HER2-positive breast cancer

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 116, Núm. 9, pp. 3863-3872

  2. Detection of novel fusion-transcripts by RNA-Seq in T-cell lymphoblastic lymphoma

    Scientific Reports, Vol. 9, Núm. 1

  3. Erratum: Therapeutic targeting of HER2-CB2R heteromers in HER2-positive breast cancer (Proceedings of the National Academy of Sciences of the United States of America (2019) 116 (3863–3872) DOI: 10.1073/pnas.1815034116)

    Proceedings of the National Academy of Sciences of the United States of America

  4. Multifunctional albumin-stabilized gold nanoclusters for the reduction of cancer stem cells

    Cancers, Vol. 11, Núm. 7

  5. S194-P-FADD as a marker of aggressiveness and poor prognosis in human T-cell lymphoblastic lymphoma

    Carcinogenesis, Vol. 40, Núm. 10, pp. 1260-1268

2018

  1. Pathway-specific control of striatal neuron vulnerability by corticostriatal cannabinoid CB 1 receptors

    Cerebral Cortex, Vol. 28, Núm. 1, pp. 307-322

  2. The APPswe/PS1A246E mutations in an astrocytic cell line leads to increased vulnerability to oxygen and glucose deprivation, Ca 2+ dysregulation, and mitochondrial abnormalities

    Journal of Neurochemistry, Vol. 145, Núm. 2, pp. 170-182